NCT00239044View on ClinicalTrials.gov

An Open Label Study to Evaluate the Tolerability and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion (CsA-ME) in Maintenance Renal Transplant Recipients

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

July 31, 2005

Conditions
Kidney Transplant Recipients
Interventions
DRUG

Enteric-coated Mycophenolate sodium (EC-MPS)

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY

NCT00239044 - An Open Label Study to Evaluate the Tolerability and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion (CsA-ME) in Maintenance Renal Transplant Recipients | Biotech Hunter | Biotech Hunter